Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2023 1
2024 45
2025 64
2026 22

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

116 results

Results by year

Filters applied: . Clear all
Page 1
Improved diagnostic screening and classification of clonal mast cell diseases by ultrasensitive KIT p.D816V detection.
Navarro-Navarro P, González-Tablas M, Pérez-Pons A, Sánchez-Muñoz L, Henriques A, Álvarez-Twose I, Nafria P, Araco-Sánchez D, Morales-Cabeza C, Caligaris H, Chen L, González-de-Olano D, González-López Ó, Escribano L, García-Montero AC, Jara-Acevedo M, Orfao A. Navarro-Navarro P, et al. Blood. 2025 Nov 27;146(22):2696-2709. doi: 10.1182/blood.2025029507. Blood. 2025. PMID: 40811860 Free PMC article.
Prevalence of KIT D816V in anaphylaxis or systemic mast cell activation.
Hartmann K, Alvarez-Twose I, Bernstein JA, Akin C, Myers B, Hirdt A, Whyte AF, Anderson J, Ruëff F, Siebenhaar F, White AA, Pongdee T, Grattan CE, Jurcic JG, Bonadonna P, Triggiani M, Giannetti M, Barete S, Wedi B, Zakharyan A, Coghlan R, Hoehn G, Lugar P, Livideanu CB, Sabato V. Hartmann K, et al. J Allergy Clin Immunol. 2026 Feb;157(2):409-418. doi: 10.1016/j.jaci.2025.10.010. Epub 2025 Oct 25. J Allergy Clin Immunol. 2026. PMID: 41399928 Free article.
Telomere occupancy by TRF2 is altered by KIT mutations and correlates with mastocytosis regression.
Bruneau J, Georgin-Lavialle S, Ladraa S, Belaid Z, Plo I, Letard S, Soucie E, Draskovic I, Goudin N, Bouillié M, Lepelletier Y, Rossignol J, Polivka L, Frenzel L, Lortholary O, Fraitag S, Bodemer C, Revy P, Arock M, Molina TJ, Londono-Vallejo A, Dubreuil P, Maouche-Chretien L, Hermine O. Bruneau J, et al. Blood Cancer J. 2025 Nov 5;15(1):194. doi: 10.1038/s41408-025-01372-z. Blood Cancer J. 2025. PMID: 41193460 Free PMC article.
Phase II Study of Sunitinib in Tumors With c-KIT Mutations: Results From the NCI MATCH ECOG-ACRIN Trial (EAY131) Subprotocol V.
Gien LT, Song Z, Poklepovic A, Collisson EA, Zwiebel JA, Gray RJ, Wang V, McShane LM, Rubinstein LV, Patton DR, Williams PM, Hamilton SR, Tricoli JV, Conley BA, Arteaga CL, Harris LN, O'Dwyer PJ, Chen AP, Flaherty KT. Gien LT, et al. JCO Precis Oncol. 2024 Dec;8:e2400514. doi: 10.1200/PO-24-00514. Epub 2024 Dec 12. JCO Precis Oncol. 2024. PMID: 39666929 Free PMC article. Clinical Trial.
116 results